home / stock / nvzmy / nvzmy news


NVZMY News and Press, Novozymes A/S ADR

Stock Information

Company Name: Novozymes A/S ADR
Stock Symbol: NVZMY
Market: OTC
Website: novonesis.com/en/

Menu

NVZMY NVZMY Quote NVZMY Short NVZMY News NVZMY Articles NVZMY Message Board
Get NVZMY Alerts

News, Short Squeeze, Breakout and More Instantly...

NVZMY - Novozymes A/S Non-GAAP EPS of Euro1.49, revenue of Euro4.16B

2026-02-25 08:46:31 ET More on Novozymes A/S Novozymes A/S (NVZMY) Q4 2025 Earnings Call Transcript Novozymes A/S 2025 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Novozymes A/S Historical earnings data for Novozymes A/S ...

NVZMY - Novozymes A/S (NVZMY) Q4 2025 Earnings Call Transcript

2026-02-25 07:31:36 ET Novozymes A/S (NVZMY) Q4 2025 Earnings Call February 25, 2026 3:00 AM EST Company Participants Tobias Björklund - Head of Investor Relations Ester Baiget - President & CEO Rainer Lehmann - Executive VP & CFO Henrik Nielsen ...

NVZMY - Novozymes A/S reports Q3 results

2025-11-06 15:00:11 ET More on Novozymes A/S Novozymes A/S (NVZMY) Q3 2025 Earnings Call Transcript Novozymes A/S 2025 Q3 - Results - Earnings Call Presentation Novonesis A/S (NVZMF) Q2 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on Novo...

NVZMY - Novozymes A/S (NVZMY) Q3 2025 Earnings Call Transcript

2025-11-06 06:36:09 ET Novozymes A/S (NVZMY) Q3 2025 Earnings Call November 6, 2025 3:00 AM EST Company Participants Tobias Björklund - Head of Investor Relations Ester Baiget - President & CEO Rainer Lehmann - Executive VP & CFO Claus Fuglsang -...

NVZMY - Novonesis: Industry Leader With Defensive Characteristics And Solid Growth

2025-06-01 07:01:45 ET Summary Novonesis is a global market leader in enzymes and biosolutions, offering defensive growth and resilience across essential industries like food, agriculture, and household care. The company has delivered strong organic growth, repeatedly raising guid...

NVZMY - Novonesis A/S (NVZMF) Q1 2025 Earnings Call Transcript

2025-05-11 10:32:06 ET Novonesis A/S (NVZMF) Q1 2025 Earnings Conference Call May 08, 2025, 03:00 AM ET Company Participants Tobias Björklund - Head, Investor Relations Ester Baiget - Chief Executive Officer Rainer Lehmann - Chief Financial Officer Amy B...

NVZMY - DSM-Firmenich: Improving Fundamentals At A More Digestible Valuation

2025-02-28 17:37:54 ET Summary DSM-Firmenich's FY 2024 results show promising growth and profitability, with 6% organic sales growth and 19% adjusted EBITDA increase, despite a challenging macroeconomic environment. The company is making progress on the promised synergies, targeti...

NVZMY - Expected US Company Earnings on Thursday, February 27th, 2025

FTAI Infrastructure Inc. (FIP) is expected to report for quarter end 2024-12-31 Nautilus Biotechnology Inc. (NAUT) is expected to report $-0.16 for Q4 2024 Falconstor Software Inc (FALC) is expected to report for quarter end 2024-12-31 Payoneer Global Inc. (PAYO) is expected to report...

NVZMY - Novonesis A/S (NVZMF) Q4 2024 Earnings Call Transcript

2025-02-26 08:39:34 ET Novonesis A/S (NVZMF) Q4 2024 Earnings Conference Call February 26, 2025 03:00 AM ET Company Participants Tobias Cornelius Björklund - Head, Investor Relations Ester Baiget - Chief Executive Officer Rainer Lehmann - Chief Financial Off...

NVZMY - Novonesis A/S reports FY results

2025-02-26 03:05:08 ET More on Novonesis A/S, Novonesis A/S, etc. Novonesis: Still Too Expensive Historical earnings data for Novonesis A/S Financial information for Novonesis A/S Seeking Alpha’s Quant Rating on Novonesis A/S Historical earning...

Next 10